Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...
SGLT2 inhibitors may be a better treatment option for some older, frail patients hospitalized with heart failure, according to a study presented at the 2025 annual meeting of the Heart Failure Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results